Writing in the Health Affairs Blog, Jennifer Kates, vice president and director of Global Health & HIV Policy at the Kaiser Family Foundation, discusses findings from a new analysis by Dielemen et al. on global health funding. Kates notes the analysis raises “important questions about the future for policymakers, particularly those in donor governments and international institutions who have in large part put a premium on addressing global health as part of development over the past decade. While it appears that the global health funding revolution is likely over, policymakers will increasingly be confronted with the challenge of addressing the unfinished business of HIV, TB, malaria, MNCH, and other areas — and ensuring that their health investments are lasting — in an era of fiscal constraint (for them and for recipient countries) even as newer challenges, such as NCDs, rise on the global agenda” (4/17).